head-and-neck-cancer

Documents about head-and-neck-cancer

• A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract#136330ClinicalTrials.gov
• Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery#272359ClinicalTrials.gov
• Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists#842712ClinicalTrials.gov
• Individualization of Nutritive Sensory Support Of Radiation Therapy#882583ClinicalTrials.gov
• Optical coherence tomography assessment of tongue papillary atrophy and patient-reported impact on taste following head and neck cancer therapy#654951Spiral
• A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors#800997ClinicalTrials.gov
• Survivorship After HNC: A Randomized Controlled Trial Evaluating Patient Care and Adherence to Follow-up#858386ClinicalTrials.gov
• A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting#992898ClinicalTrials.gov
• Safety Study of AMG 228 to Treat Solid Tumors#1047394ClinicalTrials.gov
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer#834113ClinicalTrials.gov
• The influence of urban versus rural residence and travel distance on net income, out-of-pocket payments and quality of life in German head and neck cancer survivors.#396180NCBI PubMed Central
• Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma#444887ClinicalTrials.gov
• Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)#146457ClinicalTrials.gov
• A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors#1047634ClinicalTrials.gov
• A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)#856584ClinicalTrials.gov
• GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors#889624ClinicalTrials.gov
• Symptom Management to Improve Completion of Patient-reported Outcome Measures#979792ClinicalTrials.gov
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma#902352ClinicalTrials.gov
• Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine#454035ClinicalTrials.gov
• The Clinical Relevance of Immune Cells and CTC in HNSCC Patients#849100ClinicalTrials.gov
• A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen#853191ClinicalTrials.gov
• Deep sequencIng in Cutaneous Squamous CEll caRciNomas#836572ClinicalTrials.gov
• High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors#992081ClinicalTrials.gov
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO#141014ClinicalTrials.gov
• [177Lu]Lu-AKIR001 First-in-human Study#901959ClinicalTrials.gov
• MGC018 With or Without MGA012 in Advanced Solid Tumors#1046321ClinicalTrials.gov
• PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors#905590ClinicalTrials.gov
• A synergistic triple superior vortex human memory driven algorithm for head and neck cancer biomarker discovery#1041470Springer Nature OA
• A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery#845045ClinicalTrials.gov
• A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia#840094ClinicalTrials.gov
• Causal Machine Learning Analysis of Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis in Head and Neck Cancer Radiotherapy#484979Europe PMC
• SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN#864406ClinicalTrials.gov
• Training Swallowing Initiation During Expiration#868869ClinicalTrials.gov
• Axitinib and Nivolumab for the Treatment of Mucosal Melanoma#893114ClinicalTrials.gov
• Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study#138700bioRxiv / medRxiv
• AMG 319 in HPV Positive and Negative HNSCC#880348ClinicalTrials.gov
• Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers#888645ClinicalTrials.gov
• A Phase 1 Study of [225Ac]-FPI-1434 Injection#859603ClinicalTrials.gov
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC#894734ClinicalTrials.gov
• Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors#812811ClinicalTrials.gov
• Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer#863803ClinicalTrials.gov
• A Phase II Study to Evaluate the Efficacy and Safety of Salvage Preoperative PD-1 Inhibitor Combined with Chemotherapy Neoadjuvant Therapy in Recurrent and Metastatic LPSCC/HPSCC#900123ClinicalTrials.gov
• QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors#474767ClinicalTrials.gov
• An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...#837455ClinicalTrials.gov
• A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer#902741ClinicalTrials.gov
• LLMs for diagnostic support in HNCs#411643Figshare
• A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers#842351ClinicalTrials.gov
• Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination with Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy#878782ClinicalTrials.gov
• Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer#859399ClinicalTrials.gov
• Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer#810269ClinicalTrials.gov